Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for ...

Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...

Phase 1 proof-of-concept study of CLY-124 in Sickle Cell Disease expected in Q4 2026In vivo preclinical data assessing new compounds vs. standard of care in gold-standard, translatable myelofibrosis ...

The Michelin Guide has the power to change the trajectory of a restaurant, but there's a lot of misinformation out there ...

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; ...

Building a pipeline of world-class defence technologies needs greater coherence among the military, academia and industry ...

See, despite the name, the Tribute isn’t just for show - the modifications are serving a purpose as well. Or, to put it in ...

Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; ...

The Boardman Schools Fund for Educational Excellence has announced its 2025–26 teacher grant recipients, awarding 12 ...

Nandan Nilekani built Aadhaar, India’s vast digital biometric identity system. Now he wants to Aadhaarize the world.

Chiplets enable scalability but dramatically raise interconnect complexity and risk. Silicon-proven NoC technology is the key ...

Volkswagen is introducing a redesigned cockpit concept that will roll out across its electric ID. lineup, beginning with the ...